Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives
摘要:
A series of C5-substituted licofelone ([2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid) derivatives were developed by a parallel synthesis approach and investigated for cytotoxicity against MCF-7 and MDA-MB-231 cells as well as for anti-inflammatory potency in vitro and in vivo. Dependent on the C5-substituent, the compounds showed high selectivity for MCF-7 cells. Especially 2-oxoethyl benzoate derivatives were inactive at the MDA-MB-231 cell line and as active as 5-FU at MCF-7 cells. C5-acetyl (8a), -2-oxoethyl formiate (8e), -2-oxoethyl acetate (81) and -2-oxoethyl propionate (8g) derivatives showed growth inhibition at both cell lines, comparable with cisplatin. Modifications significantly reduced the inhibitory potency at COX-1 and COX-2 in vitro and in the xylene-induced ear swelling assay in mice. Only compound 8a was equipotent to licofelone, ibuprofen and celecoxibe in vivo. (C) 2011 Elsevier Masson SAS. All rights reserved.
The IR spectra of 47 1,3,2-dioxaphosphorinanes, mostly new compounds, have been recorded and discussed. Assignments have been made to PO, POC (alkyl and aryl), PS and PN stretching motions. In addition,it is suggested tentatively that multiple bands found at around 1000 to 1050 cm−1 and at around 1150 to 1200 cm−1 may be due to ring PO(C) vibrations.
记录和讨论了47种1,3,2-二氧杂磷酰萘啉(主要是新化合物)的红外光谱。分配给P,O,POC(烷基和芳基),PS和PN拉伸运动。另外,初步建议在大约1000至1050 cm -1和大约1150至1200 cm -1处发现多个频带可能是由于环PO(C)振动所致。
Method for Chlorinating Alcohols
申请人:Rohde Thorsten
公开号:US20080228016A1
公开(公告)日:2008-09-18
A process for preparing organic chlorides in which the chlorine atom is bonded to a CH
2
group by reacting the corresponding alcohols with thionyl chloride in the presence of a triaylphosphine oxide at a temperature of from 20 to 200° C. and a pressure of from 0.01 to 10 MPa abs, which comprises using the triarylphosphine oxide in a molar ratio to the amount of OH groups to be chlorinated of from 0.0001 to 0.5.
The present invention relates to compounds of general formula I,
wherein the groups R
1
, R
2
and m are defined as in claim
1
, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
[EN] NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS<br/>[FR] NOUVEAUX DÉRIVÉS D'ACIDE INDANYLOXYDIHYDROBENZOFURANNYLACÉTIQUE ET LEUR UTILISATION COMME AGONISTES DU RÉCEPTEUR GPR40
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2013144098A1
公开(公告)日:2013-10-03
The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
Process for producing intermediate furanones from diol derivative and
申请人:Hoffmann-La Roche Inc.
公开号:US04596879A1
公开(公告)日:1986-06-24
A novel process for the manufacture of the furanone of the formula ##STR1## is described. In this process, a diol is firstly reacted with thionyl chloride, then the sulphite formed, optionally after oxidation to the corresponding sulphate, is treated with sodium cyanide and the resulting hydroxynitrile is hydrolyzed. The furanone of formula I can be used as a starting material for the manufacture of R-(-)-pantolactone.